Studies on mutagenicity of 2 bronchodilators under development in Cuba

Miguel A. Jiménez, Marta Torroella, SaloméIvonne Fernández, Rolando Pellón

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


2 pyridoquinazolones, 2-amino-11H-pyrido[2,1-b]quinazolin-11-one (2-APQ) and 11H-pyrido[2,1-b]quinazolin-11-one (PQ), under development as anti-asthma drugs, were studied for mutagenicity. 2-APQ was found to be a strong mutagen in 5 strains of Salmonella typhimurium and a mild one in the forward-mutation system of the yeast Schizosaccharomyces pombe. Furthermore, 2-APQ had strong clastogenic effects in mouse bone marrow. Because of these results, development of 2-APQ as a bronchodilator was stopped. PQ, on the other hand, did not induce mutation in the 5 Salmonella strains or in S. pombe. S9 mix generally increased the response of 2-APQ in Salmonella dramatically. On the contrary, the mutagenic effectiveness of this compound in S. pombe was only slightly higher in the presence of S9 than without it, suggesting that metabolic activation was not effective in this system.

Original languageEnglish (US)
Pages (from-to)225-236
Number of pages12
JournalMutation Research/Genetic Toxicology
Issue number3-4
StatePublished - Jan 1 1983

ASJC Scopus subject areas

  • Toxicology
  • Genetics


Dive into the research topics of 'Studies on mutagenicity of 2 bronchodilators under development in Cuba'. Together they form a unique fingerprint.

Cite this